Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Reddit

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jul 20, 2022 11:17am

219 Views

Post# 34837090

RE:RE:RE:RE:RE:RE:Reddit

Agree 99942Apophis.

Let the clinical data do the work naturally and permanently instead trying to spark an artificial and not durable raise based on not yet clear enough data.

Only 5 weeks to go to have another set of data that will include fresh new data on 11 patients @270-days (60% of the road to the 450-day Durable Response (DR)), on top of overall moving data for all patients from one cystoscopy to another one.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec